Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04373343 · ClinicalTrials.gov registry record · NA
Food Addiction Clinical Treatment Program
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04373343: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT04373343 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04373343, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this current study is to establish the feasibility of, and preliminary support for, a clinical treatment program utilizing interventions from various empirically supported treatments for obesity-related eating disorders and substance use disorders
Primary Outcome
The YFAS 2.0 is a self-report measure used to assess addictive eating behaviors related to highly processed foods. The YFAS 2.0 consists of 35 items based on the DSM - 5 diagnostic criteria for substance use No Food Addiction = 0-1 symptoms/score Mild Food Addiction = 2 or 3 score Moderate Food Addiction = 4 or 5 score Severe Food Addiction = 6 or higher score
Interventions
- BEHAVIORAL 16-week Food Addiction Clinical Treatment (FACT) Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-03-21 |
| Est. Completion | 2023-09-07 |
| Phase | NA |
What the finished NCT04373343 record still lists
NCT04373343 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which 16-week Food Addiction Clinical Treatment (FACT) Program is the first listed.
NCT04373343 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04373343 about?
NCT04373343 is a clinical study titled "Food Addiction Clinical Treatment Program". The purpose of this current study is to establish the feasibility of, and preliminary support for, a clinical treatment program utilizing interventions from various empirically supported treatments for obesity-related eating disorders and substance use disorders
What is the current status of trial NCT04373343?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2023-03-21. Estimated completion is 2023-09-07.
What interventions are being tested in trial NCT04373343?
The interventions under investigation include: 16-week Food Addiction Clinical Treatment (FACT) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04373343?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04373343's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI